Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)

Study Evaluating PD-0299685 for the Treatment of Vasomotor Symptoms (Hot Flashes / Flushes) Associated With Menopause

NCT00314964 ·Status: COMPLETED ·Phase: PHASE2

Dose-ranging, PK, Safety, Efficacy Study of Osanetant in Patients With Moderate/Severe VMS Associated With Menopause

NCT05325775 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Low-dose Hormone Therapy for Relief of Vasomotor Symptoms

NCT00446199 ·Status: COMPLETED ·Phase: PHASE3

A Study to Find the Best Dose of HS-10384 to Treat Vasomotor Symptoms in Postmenopausal Women

NCT06393673 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats

NCT06049797 ·Status: ACTIVE_NOT_RECRUITING

A Study to Assess the Safety and Tolerability of Fezolinetant in Women Seeking Treatment for Relief of Vasomotor Symptoms (VMS) Associated With Menopause

NCT04451226 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause

NCT07118891 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)

NCT03192176 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS).

NCT07042516 ·Status: RECRUITING ·Phase: PHASE2

Safety/Efficacy Study of Drospirenone/Estradiol to Treat Postmenopausal Chinese Women With Vasomotor Symptoms.

NCT00356447 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of S-equol on Vasomotor Symptoms in Menopausal Patients

NCT00962585 ·Status: COMPLETED ·Phase: PHASE2

PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health

NCT06186531 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate the Effects of RAD1901 in the Treatment of Vasomotor Symptoms in Postmenopausal Women

NCT00875420 ·Status: COMPLETED ·Phase: PHASE2

Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013)

NCT00535288 ·Status: COMPLETED ·Phase: PHASE3

A Nutritional Supplement on Vasomotor Symptoms in Women

NCT04516304 ·Status: COMPLETED ·Phase: NA

A Study of BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms

NCT03596762 ·Status: COMPLETED ·Phase: PHASE2

FP-101 Versus Placebo in the Treatment of Menopausal Vasomotor Symptoms

NCT05312567 ·Status: COMPLETED ·Phase: PHASE2

A Study of NOE-115 in Women With Vasomotor Symptoms Due to Menopause

NCT06385795 ·Status: COMPLETED ·Phase: PHASE2

A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 52 Weeks in Women Who Have Been Through the Menopause

NCT05030584 ·Status: COMPLETED ·Phase: PHASE3

Vasomotor Symptoms (VMS) Progesterone Study: Vasomotor Symptoms and Endothelial Function - Trial of Oral Micronized Progesterone

NCT00152438 ·Status: UNKNOWN ·Phase: PHASE2

One Week Clinical Study in Subjects With Menopausal Symptoms

NCT06794021 ·Status: COMPLETED ·Phase: NA

A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause

NCT05042362 ·Status: COMPLETED ·Phase: PHASE3

A Double-Blind Study to Evaluate the Effect of Femarelle® on Menopausal on Vasomotor Symptoms

NCT01063725 ·Status: UNKNOWN ·Phase: NA

Evaluation of the Pharmacokinetics and Safety of BAY3427080 (NT-814) in Post-Menopausal Women With Vasomotor Symptoms

NCT02865538 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Estetrol for the Treatment of Moderate to Severe Vasomotor Symptoms in Postmenopausal Women (E4Comfort II)

NCT04090957 ·Status: COMPLETED ·Phase: PHASE3